Evidence map›Paper›PMID 39770763›Full record

ArticleMicroorganisms2024

Association of Single-Nucleotide Variants in ACE2 with the Persistence of Positive qPCR Test for SARS-CoV-2 in Healthcare Professionals During the First Wave of the COVID-19 Pandemic.

Karina Jiménez-Gil, Jorge Alberto Cerón-Albarrán, Melissa Daniella Gonzalez-Fernandez, Rosalba Sevilla-Montoya, Alberto Hidalgo-Bravo, Javier Angeles-Martínez, Daniel Montes-Herrera, Oscar Villavicencio-Carrisoza, Carmen Selene García-Romero, José Esteban Muñoz-Medina and 1 more

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Role ofInternational journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Karina Jiménez-GilReproductive and Perinatal Health Research Department, National Institute of Perinatology, Mexico City 11000, Mexico.
Jorge Alberto Cerón-AlbarránReproductive and Perinatal Health Research Department, National Institute of Perinatology, Mexico City 11000, Mexico.
Melissa Daniella Gonzalez-FernandezReproductive and Perinatal Health Research Department, National Institute of Perinatology, Mexico City 11000, Mexico.ORCID 0000-0003-1188-0843
Rosalba Sevilla-MontoyaReproductive and Perinatal Health Research Department, National Institute of Perinatology, Mexico City 11000, Mexico.ORCID 0000-0002-5658-4661
Alberto Hidalgo-BravoGenomics Medicine Department, National Institute of Rehabilitation, Mexico City 14610, Mexico.ORCID 0000-0003-2506-8784
Javier Angeles-MartínezSpecialized Laboratories Division, Mexican Social Security Institute, Mexico City 06700, Mexico.ORCID 0000-0001-5405-0482
Daniel Montes-HerreraSpecialized Laboratories Division, Mexican Social Security Institute, Mexico City 06700, Mexico.ORCID 0000-0003-2049-7387
Oscar Villavicencio-CarrisozaImmunobiochemistry Department, National Institute of Perinatology, Mexico City 11000, Mexico.ORCID 0000-0002-7091-8840
Carmen Selene García-RomeroInfectology and Immunology Department, National Institute of Perinatology, Mexico City 11000, Mexico.
José Esteban Muñoz-MedinaQuality of Supplies and Specialized Laboratories Coordination, Mexican Social Security Institute, Mexico City 37320, Mexico.
Irma Eloisa Monroy-MuñozReproductive and Perinatal Health Research Department, National Institute of Perinatology, Mexico City 11000, Mexico.ORCID 0000-0001-8737-8935

Funding

National Institute of Perinatology, Mexico 2020-1-27
6 · The paper itself

Abstract

The persistence of qPCR positivity for SARS-CoV-2 in individuals who recovered from COVID-19 raised several questions regarding viral transmission, with a special interest in healthcare professionals who may pose a risk of transmitting SARS-CoV-2. This issue highlights the necessity for identifying the genetic risk factors associated with persistent SARS-CoV-2 infection. A promising target for achieving this goal is the angiotensin-converting enzyme 2 (

Indexed as

ACE2 genetic variantsfirst wavehealthcare workerspersistencepositivitySARS-CoV-2 RT–qPCR

Identifiers

PMID39770763
PMCPMC11676041

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.